TrialThe New England journal of medicine2019

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

Joseph A Sparano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.